Cargando…

Significance of age and sex in botulinum neurotoxin dosing for adductor spasmodic dysphonia

OBJECTIVES: This study aims to analyze the impact of age and sex on botulinum neurotoxin (BoNT‐A) dosing and outcomes in adductor spasmodic dysphonia (AdSD). METHODS: A database review of all spasmodic dysphonia patients treated with BoNT from 1989 to 2018 at the Mayo Clinic in Arizona was performed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heyes, Richard, Adler, Charles H., Zhang, Nan, Lott, David G., Bansberg, Stephen F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296044/ https://www.ncbi.nlm.nih.gov/pubmed/37383332 http://dx.doi.org/10.1002/wjo2.88

Ejemplares similares

Vocal aging and adductor spasmodic dysphonia: Response to botulinum toxin injection
por: Cannito, Michael P, et al.
Publicado: (2008)

Tridimensional assessment of adductor spasmodic dysphonia pre- and post-treatment with Botulinum toxin
por: Dejonckere, P. H., et al.
Publicado: (2011)

Retrospective review of dosing trends in botulinum toxin injections for the treatment of adductor spasmodic dysphonia in a long-term cohort
por: French, Gabrielle, et al.
Publicado: (2020)

Unilateral versus bilateral thyroarytenoid Botulinum toxin injections in adductor spasmodic dysphonia: a prospective study
por: Upile, Tahwinder, et al.
Publicado: (2009)

Altered sensory system activity and connectivity patterns in adductor spasmodic dysphonia
por: Mantel, Tobias, et al.
Publicado: (2020)

Adductor spasmodic dysphonia: Botulinum toxin a injections or laser thyroarytenoid myoneurectomy? A comparison from the patient perspective
por: Schuering, Juliëtta H. C., et al.
Publicado: (2019)

Botulinum Toxin Therapy for Spasmodic Dysphonia in Japan: The History and an Update
por: Hyodo, Masamitsu, et al.
Publicado: (2022)

Treatment Efficacy of Electromyography versus Fiberscopy-Guided Botulinum Toxin Injection in Adductor Spasmodic Dysphonia Patients: A Prospective Comparative Study
por: Kim, Jae Wook, et al.
Publicado: (2014)

Use of Botulinum Toxin in Spasmodic Dysphonia: A Review of Recent Studies
por: Khan, Hammaad A
Publicado: (2023)

Adductor Spasmodic Dysphonia Improves with Bilateral Thalamic Deep Brain Stimulation: Report of 3 Cases Done Asleep and Review of Literature
por: Evidente, Virgilio Gerald H., et al.
Publicado: (2020)

Transcranial magnetic stimulation and functional magnet resonance imaging evaluation of adductor spasmodic dysphonia during phonation
por: Chen, Mo, et al.
Publicado: (2020)

Impact in Vocal Quality in Partial Myectomy and Neurectomy Endoscopic of Thyroarytenoid Muscle in Patients with Adductor Spasmodic Dysphonia
por: Tsuji, Domingos Hiroshi, et al.
Publicado: (2015)

Validity of intraoperative voice monitoring undergoing type 2 thyroplasty with titanium bridges for adductor spasmodic dysphonia
por: Sanuki, Tetsuji, et al.
Publicado: (2022)

Laryngeal Imaging Study of Glottal Attack/Offset Time in Adductor Spasmodic Dysphonia during Connected Speech
por: Naghibolhosseini, Maryam, et al.
Publicado: (2023)

Optimizing Botox regimens in patients with adductor spasmodic dysphonia and essential tremor of voice: A 31‐year experience
por: Stone, Amy, et al.
Publicado: (2022)

Long-term Dose Stability of OnabotulinumtoxinA Injection for Adductor Spasmodic Dysphonia: A 19-Year Single Institution Experience
por: Paddle, Paul, et al.
Publicado: (2017)

Botulinum Toxin Therapy: A Series of Clinical Studies on Patients with Spasmodic Dysphonia in Japan
por: Hyodo, Masamitsu, et al.
Publicado: (2021)

Anxiety and depression in spasmodic dysphonia patients
por: Hu, Amanda, et al.
Publicado: (2018)

Spasmodic dysphonia like presentation of stiff person syndrome
por: Rana, Abdul Qayyum, et al.
Publicado: (2014)

Post‐treatment clinical course following botulinum toxin injection therapy for adductor spasmodic dysphonia: Analysis of data from a placebo‐controlled, randomized, double‐blinded clinical trial in Japan
por: Hirose, Kahori, et al.
Publicado: (2021)

Hyperactive sensorimotor cortex during voice perception in spasmodic dysphonia
por: Kanazawa, Yuji, et al.
Publicado: (2020)

Adduction spasmodic dysphonia, vocal tremor and muscular tension dysphonia: is it possible to reach a differential diagnosis?
por: Imamura, Rui, et al.
Publicado: (2015)

Spasmodic dysphonia, perceptual and acoustic analysis: presenting new diagnostic tools
por: Siemons-Lühring, Denise Irene, et al.
Publicado: (2009)

Diagnosis of Spasmodic Dysphonia Manifested by Swallowing Difficulty in Videofluoroscopic Swallowing Study
por: Yeo, Han Gyeol, et al.
Publicado: (2015)

Communication‐related affective, behavioral, and cognitive reactions in speakers with spasmodic dysphonia
por: Watts, Christopher R., et al.
Publicado: (2017)

Laryngeal vibration as a non-invasive neuromodulation therapy for spasmodic dysphonia
por: Khosravani, Sanaz, et al.
Publicado: (2019)

Machine Learning Assessment of Spasmodic Dysphonia Based on Acoustical and Perceptual Parameters
por: Calà, Federico, et al.
Publicado: (2023)

Long-term Effect of Sodium Oxybate (Xyrem®) in Spasmodic Dysphonia with Vocal Tremor
por: Simonyan, Kristina, et al.
Publicado: (2013)

Intramuscular Neural Distribution of Adductor Pollicis Muscle Spasticity in Cadaver Model Regarding Botulinum Neurotoxin Treatment
por: Yi, Kyu-Ho, et al.
Publicado: (2023)

Demographics and coexisting tremor, cervical dystonia and vocal fold disorders in a group of patients with spasmodic dysphonia
por: Karatayli Ozgursoy, Selmin, et al.
Publicado: (2020)

Adductor focal laryngeal Dystonia: correlation between clinicians’ ratings and subjects’ perception of Dysphonia
por: Stewart, Celia Faye, et al.
Publicado: (2017)

On Botulinum Neurotoxin Variability
por: Montecucco, Cesare, et al.
Publicado: (2015)

The Zinc-Dependent Protease Activity of the Botulinum Neurotoxins
por: Lebeda, Frank J., et al.
Publicado: (2010)

Botulinum toxin injection into the intrinsic laryngeal muscles to treat spasmodic dysphonia: A multicenter, placebo‐controlled, randomized, double‐blinded, parallel‐group comparison/open‐label clinical trial
por: Hyodo, Masamitsu, et al.
Publicado: (2021)

Why Are Botulinum Neurotoxin-Producing Bacteria So Diverse and Botulinum Neurotoxins So Toxic?
por: Poulain, Bernard, et al.
Publicado: (2019)

Thalamic Deep Brain Stimulation for Spasmodic Dysphonia: A Phase I Prospective Randomized Double-Blind Crossover Trial
por: Honey, Christopher R, et al.
Publicado: (2021)

Zebrafish Sensitivity to Botulinum Neurotoxins
por: Chatla, Kamalakar, et al.
Publicado: (2016)

Use of Botulinum Neurotoxin in Ophthalmology
por: Başar, Emel, et al.
Publicado: (2016)

Antipruritic Effects of Botulinum Neurotoxins
por: Gazerani, Parisa
Publicado: (2018)

Therapy of Sialorrhea with Botulinum Neurotoxin
por: Jost, Wolfgang H., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d16hoi43itij873e1cea998vaj